Main Page
About PACER-HD
Director
Summary
Vision Mission Goals
Dedication
Management
Management Structure
Board of Directors
Administration
Research Groups
Research Focus
rare genetic disorders
In vitro developmental & functional studies
single gene disorders
Drug screening and discovery
3D modeling of genetic disorders
Research
Researchers Publications
Services
Laboratory Services
Medical Services
Serving the Community
Pamphlets
EVENTS
EBM
Opportunities for training
Special programs
Latest News
News Archive
Visits
Global Events
Local Events
Lectures
Announcements
Media file
PhotoAlbum
Video Library
Newspapers & Magazines
Files
Links
Location Map
Contact us
عربي
English
About
Admission
Academic
Research and Innovations
University Life
E-Services
Search
Princess Al-Jawhara Center of Excellence in Research of Hereditary Disorders
Document Details
Document Type
:
Article In Journal
Document Title
:
Treatment of steroid resistant nephritic syndrome in children
علاج متلازمة مقاومة الستيرويد الكلوي لدى الأطفال
Subject
:
Hereditary Disorders
Document Language
:
English
Abstract
:
Achieving remission in children with Steroid-Resistant Nephrotic Syndrome (SRNS) could be difficult. Many immunosuppressive drugs are used with variable success rates. We have studied the response of children with SRNS who presented to our pediatric's renal unit between 2002 and 2007 to various modalities of therapy. We included patients with no response to prednisolone (60 mg/M 2 /day) after four weeks of therapy; all the patients had renal biopsy and followup duration for at least one year. We excluded patients with congenital nephrotic syndrome, lupus, or sickle cell disease. There were 31 (23 girls and 8 boys with F: M= 2.9:1; the mean age at presentation was 4.2 ± 3.2) children who fulfilled the inclusion criteria. The mean duration of follow up was 3.1 ± 1.6 years. Twenty children (65%) achieved partial (6 children) or complete (14 children) remission. There were 16 children treated with cyclophosphamide either oral or intravenous, and only 4 of them (25%) achieved remission. Seven children received oral chlorambucil, and only2 of them (28.5%) achieved remission; none of the children experienced side effects. Fifteen children received cyclosporine, and only eight of them (53%) achieved remission. Six children developed gum hypertrophy and one had renal impairment, which was reversible after discontinuing the drug. Mycophonelate mofetil (MMF) was used as the last option in 5 children, and 2 of them achieved complete remission. One child developed a systemic cytomegalovirus (CMV) infection which indicated discontinuing the drug. Fourteen (45%) children needed more than one immunosuppressive therapy. Three children progressed to end stage renal failure and required dialysis. We conclude that SRNS in children is a difficult disease with significant morbidity. However, remission is achievable with cyclosporine and other immunosuppressive agents. Treatment should be individualized according to the underlying histopathology, and clinical and social conditions of the children.
ISSN
:
1319-2442
Journal Name
:
Saudi Journal of Kidney Diseaeses and Transplantation
Volume
:
21
Issue Number
:
3
Publishing Year
:
1431 AH
2010 AD
Article Type
:
Article
Added Date
:
Monday, May 30, 2011
Researchers
Researcher Name (Arabic)
Researcher Name (English)
Researcher Type
Dr Grade
Email
جميلة قاري
Qari, Jameela
Investigator
Doctorate
Files
File Name
Type
Description
29803.pdf
pdf
Back To Researches Page